연구성과로 돌아가기
2024 연구자 정보 (53 / 1079)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Author Name | 제1저자 여부 | 교신저자 여부 | Address | ResearcherID | ORCID | Paper Title | WoS Edition | 최상위 JCR(%) | WoS Category | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
|
Yadav, Monica (Yadav, M) |
|
|
[JCR상위 1.7] An interpretable AI-derived radiology signature to identify patients at risk of progression on the PACIFIC regimen for unresectable non-small cell lung cancer [JCR상위 1.7] CheckpointPx: A predictive radiology AI model of immune checkpoint inhibitor (ICI) benefit in non-small cell lung cancer (NSCLC) [JCR상위 1.7] Pre-treatment CT radiomics for predicting immunotherapy response in non-small cell lung cancer(NSCLC): RECIST vs. irRECIST criteria [JCR상위 1.7] Harmonization radiomics model to predict immune checkpoint inhibitor-related pneumonitis (CIP) in patients with non-small cell lung cancer (NSCLC) [JCR상위 1.7] AI-based radiomics model for predicting immune checkpoint inhibitor-related pneumonitis (CIP) in patients with advanced NSCLC: An external validation study |
SCIE | 1.7 | ONCOLOGY | ||||
|
Yang, Sheng-Shun (Yang, SS) |
Taichung Vet Gen Hosp, Taichung, Taiwan |
|
|
[JCR상위 1.7] Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | limys@amc.seoul.kr; | ||
|
Yi, Kiyoun (Yi, K) |
Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Internal Med, Coll Med, Busan, South Korea Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea Pusan Natl Univ, Pusan Natl Univ Hosp, Coll Med, Pusan, South Korea |
|
|
[JCR상위 1.7] Beneficial effect of combined radiation therapy in atezolizumab plus bevacizumab treatment of hepatocellular carcinoma patients with main portal vein tumor thrombosis [JCR상위 4.4] BENEFICIAL EFFECT OF COMBINED RADIATION THERAPY IN ATEZOLIZUMAB PLUS BEVACIZUMAB TREATMENT OF HEPATOCELLULAR CARCINOMA PATIENTS WITH MAIN PORTAL VEIN TUMOR THROMBOSIS OR BILE DUCT INVASION |
SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | jheo@pusan.ac.kr; | ||
|
Yoo, Chang Hak (Yoo, CH) |
Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Surg, Sch Med, Seoul, South Korea |
|
|
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | SCIE | 1.7 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Yoo, Moon-Won (Yoo, MW) |
Univ Ulsan, Asan Med Ctr, Dept Surg, Seoul, South Korea |
|
|
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | SCIE | 1.7 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Yook, Jeong Hwan (Yook, JH) |
Univ Ulsan, Asan Med Ctr, Dept Surg, Seoul, South Korea |
|
|
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | SCIE | 1.7 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Yu, Jisang (Yu, J) |
Northwestern Univ, Feinberg Sch Med, Chicago, IL USA |
|
0000-0002-4370-947X Yu, Jisang |
[JCR상위 1.7] An interpretable AI-derived radiology signature to identify patients at risk of progression on the PACIFIC regimen for unresectable non-small cell lung cancer [JCR상위 1.7] Pre-treatment CT radiomics for predicting immunotherapy response in non-small cell lung cancer(NSCLC): RECIST vs. irRECIST criteria [JCR상위 1.7] Harmonization radiomics model to predict immune checkpoint inhibitor-related pneumonitis (CIP) in patients with non-small cell lung cancer (NSCLC) [JCR상위 37.6] Redefining Clinical Hyperprogression: The Incidence, Clinical Implications, and Risk Factors of Hyperprogression in Non-Small Cell Lung Cancer Treated with Immunotherapy |
SCIE | 1.7 | ONCOLOGY | YCHAE@nm.org; | ||
|
Yu, Ming-Lung (Yu, ML) |
Natl Sun Yat Sen Univ, Kaohsiung, Taiwan |
C-9540-2009 Yu, Ming-Lung |
|
[JCR상위 1.7] Multinational randomized trial to investigate the efficacy of tenofovir alafenamide in reducing adverse clinical events in chronic hepatitis B patients who are beyond treatment indications by current guidelines (ATTENTION trial): first interim analysis | SCIE | 1.7 | GASTROENTEROLOGY & HEPATOLOGY | limys@amc.seoul.kr; | ||
|
Yun, Kum-Hee (Yun, KH) |
Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea |
|
0009-0006-5268-3191 Yun, Kum-Hee |
[JCR상위 1.7] Phase IB/II trial of durvalumab plus doxorubicin combination in patients with advanced soft-tissue sarcoma [JCR상위 7.0] Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial |
SCIE | 1.7 |
ONCOLOGY MULTIDISCIPLINARY SCIENCES |
hyosong77@yuhs.ac; | ||
|
Zang, Dae Young (Zang, DY) |
Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea |
|
|
[JCR상위 1.7] Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | SCIE | 1.7 | ONCOLOGY | ykkang@amc.seoul.kr; | ||
|
Zanoletti, Alessandra (Zanoletti, A) |
교신저자 | Univ Brescia, Dept Mech & Ind Engn, INSTM & Chem Technol Lab, Via Branze 38, I-25123 Brescia, Italy |
AAC-9945-2022 Zanoletti, Alessandra |
0000-0003-0225-7048 Zanoletti, Alessandra |
[JCR상위 1.7] Skin protection from solar ultraviolet radiation using natural compounds: a review | SCIE | 1.7 | CHEMISTRY, MULTIDISCIPLINARY;ENVIRONMENTAL SCIENCES;ENGINEERING, ENVIRONMENTAL | ankit.verma@mail.huji.ac.il;alessandra.zanoletti@unibs.it;2021321530@knu.ac.kr;adelodun.b@unilorin.edu.ng;kumarpankajgkv@gmail.com;foajibade@futa.edu.ng;lsilva8@cuc.edu.co;ankurphillips245@gmail.com;tkarthees@gmail.com;elza.bontempi@unibs.it;ashish.dwivedi1@iitr.res.in; | |
|
Zhang, Kai (Zhang, K) |
|
|
[JCR상위 1.7] An interpretable AI-derived radiology signature to identify patients at risk of progression on the PACIFIC regimen for unresectable non-small cell lung cancer [JCR상위 1.7] CheckpointPx: A predictive radiology AI model of immune checkpoint inhibitor (ICI) benefit in non-small cell lung cancer (NSCLC) [JCR상위 1.7] AI-based radiomics model for predicting immune checkpoint inhibitor-related pneumonitis (CIP) in patients with advanced NSCLC: An external validation study |
SCIE | 1.7 | ONCOLOGY | ||||
|
Zheng, Tiantian (Zheng, T) |
|
|
[JCR상위 1.7] Prognostic significance of ctDNA mutation analysis in patients with HER2-positive breast cancer undergoing neoadjuvant chemotherapy. | SCIE | 1.7 | ONCOLOGY | ||||
|
Zotkiewicz, Magdalena (Zotkiewicz, M) |
AstraZeneca, Oncol Biometr, Late Oncol Stat, Warsaw, Poland |
|
|
[JCR상위 1.7] EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization. [JCR상위 1.7] mRECIST outcomes in EMERALD-1: a phase 3, randomized, placebo-controlled study of transarterial chemoembolization plus durvalumab with/without bevacizumab in participants with embolization-eligible hepatocellular carcinoma |
SCIE | 1.7 |
ONCOLOGY GASTROENTEROLOGY & HEPATOLOGY |
bsangro@unav.es; | ||
|
Chang, Mingi (Chang, M) |
제1저자 | Kyungpook Natl Univ, Coll Nursing, Daegu, South Korea |
|
0000-0003-1338-9396 Mingi, Chang |
[JCR상위 1.8] Effects of a mobile-based bioterrorism response program among clinical nurses: A quasi-experimental study | SCIE;SSCI | 1.8 | EDUCATION, SCIENTIFIC DISCIPLINES;NURSING | yujeongkim@knu.ac.kr; |
페이지 이동: